Arcutis Biotherapeutics, Inc. (ARQT)
20.66
-3.51
(-14.52%)
USD |
NASDAQ |
May 07, 16:00
20.73
+0.07
(+0.34%)
Pre-Market: 08:33
Arcutis Biotherapeutics Research and Development Expense (Annual) : 77.05M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Repligen Corp. | 51.31M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Corcept Therapeutics, Inc. | 254.91M |
| Amicus Therapeutics, Inc. | 135.84M |
| PTC Therapeutics, Inc. | 455.25M |